Corporate Spotlight

Telix at AdMeTech Foundation’s 6th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer

20 September 2022 | Corporate Spotlight | Telix at AdMeTech Foundation’s 6th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer

We are pleased to announce that Telix is supporting AdMeTech Foundation’s 6th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer, to be held virtually from September 22-24 2022.

The event will include a sponsored symposium on ‘Precision Diagnostics of Prostate Cancer with uEXPLORER® and Illuccix®’ by Brandon Mancini, MD, MBA, FACRO (Medical Director – Grand Rapids Clinic, BAMF Health) and Harshad R. Kulkarni, MD (Chief Medical Advisor, BAMF Health). 

In addition, Telix will present an abstract on ‘The Role of androgen receptor blockade in PSMA expression using 68Ga-PSMA-11 PET/CT imaging in patients with metastatic castrate resistant prostate cancer’, which will be published on the AdMeTech and the Grand Rounds in Urology (GRU) websites and newsletters.

For more information and to register for the event, click here.

To view the conference program please click here.

To view Telix’s accepted abstract please click here.

To return to the Telix homepage please click here.